Happi Staff11.12.20
This month, Evonik will complete the consolidation of its European manufacturing activities for fabric softener ingredients to its production sites in Steinau, Germany and Shanghai, China, and subsequently close its Granollers site near Barcelona in Spain.
Evonik’s Care Solutions business line is part of the Evonik growth division Nutrition & Care. Following a series of strategic acquisitions and inhouse innovations in recent years, the business line is transforming itself into a wide specialty technology leader. It is now positioned to serve as a preferred supplier and development partner to help customers address the functional, convenience and sustainability needs of consumers.
“Together, Evonik’s Care Solutions people continue the successful transformation of the business by improving the asset network and cost position while investing further in innovation for better sustainable ingredients, as demonstrated with the recent launches of our rhamnolipid biosurfactant,” said Yann d'Hervé, head of Evonik's Care Solutions business line.
As part of the consolidation, which was first announced in 2018, Evonik will terminate production at its Granollers site near Barcelona in Spain. In a reflection of Evonik’s commitment to social responsibility, the company has reached an agreement with the employee representatives for all of the site’s 51 employees.
Evonik’s Care Solutions business line is part of the Evonik growth division Nutrition & Care. Following a series of strategic acquisitions and inhouse innovations in recent years, the business line is transforming itself into a wide specialty technology leader. It is now positioned to serve as a preferred supplier and development partner to help customers address the functional, convenience and sustainability needs of consumers.
“Together, Evonik’s Care Solutions people continue the successful transformation of the business by improving the asset network and cost position while investing further in innovation for better sustainable ingredients, as demonstrated with the recent launches of our rhamnolipid biosurfactant,” said Yann d'Hervé, head of Evonik's Care Solutions business line.
As part of the consolidation, which was first announced in 2018, Evonik will terminate production at its Granollers site near Barcelona in Spain. In a reflection of Evonik’s commitment to social responsibility, the company has reached an agreement with the employee representatives for all of the site’s 51 employees.